Monoclonal gammopathy of unknown significance in kidney transplanted patients
ERA Endorsements
How to obtain the ERA endorsement
ERA can give endorsement to scientific events, courses, and congresses organised by third parties. To obtain the ERA endorsement and promote the initiative on this page, read the regulations and fill in the application form.
ERA can grant non-financial support to long-term projects of third parties as forums and websites scientifically valuable or educationally significant and deal with kidney or related topics. To request the ERA non-financial support, read the regulations and fill in the application form.
XIV International Conference on Hypertension and the Kidney
March 6-8, 2024
Madrid, Spain
Comprehensive Updates in Nephrology – 2024
ZKC Preparation Course for the ESENeph 2024
March 18-19, 2024
Zurich, Switzerland
International Summer School in Renal Pathology and Precision Medicine
June 10-21, 2024
Bari, Italy
21st International Congress of renal nutrition and metabolism 2024 (ICRNM 24)
August 28-31, 2024
Hyderabad, India
Cardiometabolic Forum
The Cardiometabolic Forum provides a single source of information relating to the treatment of cardiometabolic disease. Its aims are to present the latest research for clinicians to be able to assimilate and utilise in clinical practice to optimise treatment and improve outcomes for patients. The objective is to ensure rapid and easy access to research and education so that busy clinicians have a reliable resource for the latest information to use in their clinical management of patients and in delivering their own educational initiatives.
Vascular access handbook for people with kidney disease
By the Spanish Multidisciplinary Vascular Access Group (GEMAV)
Nobody Left Outside
The Nobody Left Outside (NLO) initiative is a collective of organisations representing people in some of the most marginalised communities in Europe, including homeless people, LGTBI people, people who use drugs, prisoners, sex workers and undocumented migrants. Read more here.